Learn all the StarRupture controls and key bindings on PC, including movement, combat actions, inventory shortcuts, and UI ...

Its Project Ava-based anime avatars answer your questions, see what’s on your screen, and even see you via webcam.

Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and ...

A new study reveals that nerve cells receive periodic infusions of mitochondria from neighboring cells — and this may point ...

Obesity is a global epidemic and a major cause of morbidity and mortality because it increases the risk for comorbidities, ...

Using ribosome engineering (RE), researchers from Shinshu University introduced mutations affecting the protein synthesis ...

A new study published in Engineering reveals that NSUN2, a key protein involved in RNA modification, significantly ...

Coherus Oncology formally introduces non-proprietary name: tagmokitug--Publication shows picomolar affinity for CCR8 with no off-target binding ...

In a year defined by gold’s surge and a shift in sentiment, 31 ASX mining stocks graduated from junior hopefuls to $500m-plus ...

New obesity drugs could be inspired by discovery of an enzyme that controls both weight gain and cholesterol levels in animal ...

Investing.com -- Coherus BioSciences Inc (NASDAQ:CHRS) stock rose 5.8% on Monday following the publication of research supporting the potential of its investigational cancer treatment tagmokitug.

Coherus Oncology (CHRS) announced the publication of preclinical and clinical biomarker research in Molecular Cancer Therapeutics describing the ...